The Genitourinary Malignancies Research Center, formed in 2018, focuses on advancing discoveries to better understand, diagnose and treat cancer of the prostate, bladder and kidney. The center is a cross-institute partnership with members from Cleveland Clinic’s Lerner Research Institute, Taussig Cancer Institute and Glickman Urological & Kidney Institute to leverage clinical strengths and a diverse patient population for translational and clinical studies.
The center is led by Nima Sharifi, MD, who holds appointments in all three institutes. Dr. Sharifi is an expert in cancer endocrinology and metabolism, specifically prostate cancer.
The overarching goal of the center is to make practice-changing discoveries in genitourinary cancer. Combining the expertise of our medical oncologists, urologists, pathologists and radiation oncologists with disease-focused basic scientists will help us to rapidly bring transformative changes to clinical practice at Cleveland Clinic and around the world.
Multidisciplinary investigators in the Genitourinary Malignancies Research Center study cancers of the genitourinary system, with special emphasis on prostate, bladder and kidney cancer.
